AGP Executive Report
Last update: 6 hours agoCancer Access: India has cut prices for 543 cancer medicines, with some reductions exceeding 90%; new maximum retail prices take effect November 9, though key drugs are unaffected. Pharma Trade: India’s medicine exports rose 4.9% to $16.14 billion in the first half of FY27, led by stronger European demand. Heart Health: A review pooling data from 2.38 million adults across 11 Asian countries found cardiovascular disease affects about one in 20; obesity and other major risk factors remain widespread. Ageing China: People aged 65 and over now outnumber children under 15, increasing pressure on pensions, healthcare and long-term care. Japan Oncology: Tanabe Pharma has filed for approval of ZYNLONTA for relapsed or refractory lymphoma, based on a Japanese study showing a 58.1% response rate. Disaster Response: Cyclone Arnab has killed at least seven people in Andhra Pradesh, where more than 180,000 were evacuated.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
